News
China Treats First International Patient with World’s First Approved Solid Tumour CAR-T Therapy
The first international patient to receive Satri-cel, the newly approved CAR-T therapy for solid tumours, has successfully completed leukapheresis at Jiahui International Cancer Center in Shanghai.

